Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
<h4>Background</h4>Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence...
Saved in:
| Main Authors: | Geoffrey K Spurling, Peter R Mansfield, Brett D Montgomery, Joel Lexchin, Jenny Doust, Noordin Othman, Agnes I Vitry |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-10-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1000352 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality of pharmaceutical advertisements in medical journals: a systematic review.
by: Noordin Othman, et al.
Published: (2009-07-01) -
Physician awareness of drug cost: a systematic review.
by: G Michael Allan, et al.
Published: (2007-09-01) -
ANALYSIS OF PHARMACEUTICAL COMPANIES’ ACTIVITIES THAT ARE DIRECTED TO PHYSICIANS IN EGYPT
by: M. M. Bahlol, et al.
Published: (2016-03-01) -
Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.
by: Hneine Brax, et al.
Published: (2017-01-01) -
Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing
by: A. A. Chernov, et al.
Published: (2018-09-01)